These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 32512186)
1. Authors of clinical trials seldom reported details when declaring their individual and institutional financial conflicts of interest: a cross-sectional survey. Hakoum MB; Noureldine H; Habib JR; Abou-Jaoude EA; Raslan R; Jouni N; Hasbani DJ; Lopes LC; Guyatt G; Akl EA J Clin Epidemiol; 2020 Nov; 127():49-58. PubMed ID: 32512186 [TBL] [Abstract][Full Text] [Related]
2. Authors of clinical trials reported individual and financial conflicts of interest more frequently than institutional and nonfinancial ones: a methodological survey. Hakoum MB; Jouni N; Abou-Jaoude EA; Hasbani DJ; Abou-Jaoude EA; Lopes LC; Khaldieh M; Hammoud MZ; Al-Gibbawi M; Anouti S; Guyatt G; Akl EA J Clin Epidemiol; 2017 Jul; 87():78-86. PubMed ID: 28412465 [TBL] [Abstract][Full Text] [Related]
3. Association of author's financial conflict of interest with characteristics and outcome of rheumatoid arthritis randomized controlled trials. Khan NA; Nguyen CL; Khawar T; Spencer H; Torralba KD Rheumatology (Oxford); 2019 May; 58(5):776-785. PubMed ID: 30535001 [TBL] [Abstract][Full Text] [Related]
4. Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials. Pang WK; Yeter KC; Torralba KD; Spencer HJ; Khan NA Int J Rheum Dis; 2015 Jul; 18(6):606-15. PubMed ID: 26012523 [TBL] [Abstract][Full Text] [Related]
5. Reporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association Infobase. Shnier A; Lexchin J; Romero M; Brown K BMC Health Serv Res; 2016 Aug; 16(a):383. PubMed ID: 27528247 [TBL] [Abstract][Full Text] [Related]
6. Reporting of conflicts of interest by authors of primary studies on health policy and systems research: a cross-sectional survey. Hakoum MB; Bou-Karroum L; Al-Gibbawi M; Khamis AM; Raslan AS; Badour S; Agarwal A; Alturki F; Guyatt G; El-Jardali F; Akl EA BMJ Open; 2020 Jul; 10(7):e032425. PubMed ID: 32690493 [TBL] [Abstract][Full Text] [Related]
7. Industry compensation and self-reported financial conflicts of interest among authors of highly cited peripheral artery disease studies. Bellomo TR; Hwang C; Spector-Bagdady K; Stanley JC; Corriere MA J Vasc Surg; 2020 Aug; 72(2):673-684. PubMed ID: 31980241 [TBL] [Abstract][Full Text] [Related]
8. Transparency ethics in practice: Revisiting financial conflicts of interest disclosure forms in clinical practice guidelines. Lu Y; Jones DJ; Sharara N; Kaltenbach T; Laine L; McQuaid K; Soetikno R; Subramanian V; Barkun A PLoS One; 2017; 12(8):e0182856. PubMed ID: 28841650 [TBL] [Abstract][Full Text] [Related]
9. Financial conflicts of interest among National Comprehensive Cancer Network clinical practice guideline panelists in 2019. Desai AP; Chengappa M; Go RS; Poonacha TK Cancer; 2020 Aug; 126(16):3742-3749. PubMed ID: 32497271 [TBL] [Abstract][Full Text] [Related]
10. Reporting of Financial and Non-financial Conflicts of Interest in Systematic Reviews on Health Policy and Systems Research: A Cross Sectional Survey. Bou-Karroum L; Hakoum MB; Hammoud MZ; Khamis AM; Al-Gibbawi M; Badour S; Justina Hasbani D; Cruz Lopes L; El-Rayess HM; El-Jardali F; Guyatt G; Akl EA Int J Health Policy Manag; 2018 Aug; 7(8):711-717. PubMed ID: 30078291 [TBL] [Abstract][Full Text] [Related]
11. A new method for scoring financial conflicts of interest. Maharaj SV Int J Occup Environ Health; 2015; 21(1):49-52. PubMed ID: 25633929 [TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan. Murayama A; Ozaki A; Saito H; Sawano T; Shimada Y; Yamamoto K; Suzuki Y; Tanimoto T PLoS One; 2020; 15(10):e0239610. PubMed ID: 33048952 [TBL] [Abstract][Full Text] [Related]
13. Self-declared stock ownership and association with positive trial outcome in randomized controlled trials with binary outcomes published in general medical journals: a cross-sectional study. Falk Delgado A; Falk Delgado A Trials; 2017 Jul; 18(1):354. PubMed ID: 28747226 [TBL] [Abstract][Full Text] [Related]
15. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079 [TBL] [Abstract][Full Text] [Related]
16. Authors' self-declared financial conflicts of interest do not impact the results of major cardiovascular trials. Aneja A; Esquitin R; Shah K; Iyengar R; Nisenbaum R; Melo M; Matthewkutty S; Sethi SS; Mamdani M; Farkouh ME J Am Coll Cardiol; 2013 Mar; 61(11):1137-43. PubMed ID: 23395075 [TBL] [Abstract][Full Text] [Related]
18. Undisclosed payments by pharmaceutical and medical device manufacturers to authors of endoscopy guidelines in the United States. Bansal R; Khan R; Scaffidi MA; Gimpaya N; Genis S; Bukhari A; Dhillon J; Dao K; Bonneau C; Grover SC Gastrointest Endosc; 2020 Feb; 91(2):266-273. PubMed ID: 31738925 [TBL] [Abstract][Full Text] [Related]
19. Dependability of results in conference abstracts of randomized controlled trials in ophthalmology and author financial conflicts of interest as a factor associated with full publication. Saldanha IJ; Scherer RW; Rodriguez-Barraquer I; Jampel HD; Dickersin K Trials; 2016 Apr; 17(1):213. PubMed ID: 27113767 [TBL] [Abstract][Full Text] [Related]
20. Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology. Riechelmann RP; Wang L; O'Carroll A; Krzyzanowska MK J Clin Oncol; 2007 Oct; 25(29):4642-7. PubMed ID: 17925561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]